Please login to the form below

Not currently logged in
Email:
Password:

EUSA Pharma

This page shows the latest EUSA Pharma news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on EUSA drug

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on EUSA drug

News from pharma, biotech and healthcare. Minister’s resignation throws Brexit plan into disarray. ... EUSA’s Fotivda approved for NHS use in Scotland. Specialist pharma company EUSA Pharma has welcomed the Scottish Medicines Consortium approval of

Latest news

  • NICE backs EUSA's RCC treatment Fotivda NICE backs EUSA's RCC treatment Fotivda

    The UK’s cost-effectiveness watchdog recommends its first-line use. EUSA Pharma has won NICE backing for Fotivda (tivozanib) as a first-line treatment for advanced renal cell carcimona (RCC). ... Lee Morley, chief executive officer for EUSA Pharma, said

  • EUSA receives European green light for kidney cancer treatment Fotivda EUSA receives European green light for kidney cancer treatment Fotivda

    European Commission approves the drug to treat RCC. The European Commission (EC) has approved EUSA Pharma’s vascular endothelial growth factor receptor (VEGFR) inhibitor Fotivda (tivozaniv) as a first-line treatment ... EUSA Pharma, which was formed in

  • Samsung Bioepis wins CHMP nod for second Humira biosimilar Samsung Bioepis wins CHMP nod for second Humira biosimilar

    Novartis' CDK4/6 inhibitor Kisqali (ribociclib) got the nod for the treatment of locally advanced or metastatic breast cancer - three months after getting FDA approval in breast cancer - while Eusa Pharma ... Tivozanib - originally developed by Aveo

  • Havas Lynx excels at PM Society Awards Havas Lynx excels at PM Society Awards

    Craft Award for Direct Mail - Sudler London for Pfizer. Craft Award for Sales Aid - Frontera London for EUSA Pharma . ... Primary Care Campaign - Havas Lynx for ViiV Healthcare. Secondary Care Campaign - Frontera London for EUSA Pharma.

  • Shire drawn into Luxembourg tax haven exposé Shire drawn into Luxembourg tax haven exposé

    Investigations into Luxembourg's tax activities certainly stretch back several years, and this is not the first time that a pharma company has been implicated in the practice. ... Other pharma companies appearing in an ICIJ database of leaked documents -

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Pharma deals in March 2015 Pharma deals in March 2015

    The other deal of interest is the re-emergence of EUSA Pharma with products acquired from Jazz Pharmaceuticals. ... investor, Essex Woodlands, has bought back products worth $27m and the EUSA Pharma name from Jazz for an undisclosed amount.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Nigel Brooksby and Dr Tim Corn join the pharma group. Neurocentrx, a UK-based pharmaceutical company, has appointed Nigel Brooksby (pictured right) as non-executive chairman. ... Joining Brooksby is EUSA Pharma’s former chief medical officer Dr Tim Corn

  • EUSA Pharma appoints Rolf Hoffmann to its board EUSA Pharma appoints Rolf Hoffmann to its board

    He most recently worked at Amgen for over a decade. Oncology-focused pharmaceutical group EUSA Pharma has added to its board of directors in the form of Rolf Hoffman. ... Hoffman said: “I have watched EUSA Pharma’s remarkable progress in the three

  • EUSA Pharma adds William Crouse to board of directors EUSA Pharma adds William Crouse to board of directors

    Comes as firm hopes to become global leader in biotechnology. EUSA Pharma has appointed William Crouse to its board of directors. ... Bryan Morton, executive chairman at EUSA Pharma, said: “We have great ambitions for EUSA, and plan to grow our

  • EUSA Pharma appoints Lee Morley as its new chief executive EUSA Pharma appoints Lee Morley as its new chief executive

    EUSA Pharma has appointed Lee Morley to be its new chief executive officer, taking over from Bryan Morton who becomes the UK specialty pharmaceutical company's executive chairman. ... Commenting on the appointments Bryan Morton said: “We are delighted

  • EUSA Pharma founder to chair Glide Pharma EUSA Pharma founder to chair Glide Pharma

    Morton was most recently chief executive at oncology specialist EUSA Pharma – a company he also founded. ... EUSA was sold to Jazz Pharmaceuticals in 2012 for $700m. His other entrepreneurial experience in the industry includes founding Zeneus Pharma,

More from appointments
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Big wins for Frontera at the 2016 PM Awards

    Two golds:. Caphosol secondary care campaign and the associated sales aid, developed for EUSA Pharma. The materials have been designed around real patient stories to convey the devastation of oral mucositis ... Two silvers:. Caphosol advertisement

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics